Last $103.27 USD
Change Today +1.10 / 1.08%
Volume 744.0K
ZMH On Other Exchanges
New York
As of 1:35 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

zimmer holdings inc (ZMH) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/24/14 - $108.33
52 Week Low
08/29/13 - $78.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZIMMER HOLDINGS INC (ZMH)

zimmer holdings inc (ZMH) Related Businessweek News

No Related Businessweek News Found

zimmer holdings inc (ZMH) Details

Zimmer Holdings, Inc., through its subsidiaries, designs, develops, manufactures, and markets orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The company offers orthopedic reconstructive devices that restore function lost due to disease or trauma in joints such as knees, hips, shoulders, and elbows; dental reconstructive implants, which restore function and aesthetics in patients who have lost teeth due to trauma or disease; spinal devices that are utilized by orthopedic surgeons and neurosurgeons in the treatment of degenerative diseases, deformities, and trauma in various regions of the spine; and trauma devices used primarily to reattach or stabilize damaged bone and tissue to support the body’s natural healing process. It also provides related surgical products comprising surgical supplies and instruments designed to aid in orthopedic surgical procedures and post-operation rehabilitation; and other healthcare related services. The company’s principal customers include orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, and healthcare dealers, as well as agents, healthcare purchasing organizations, or buying groups. Zimmer Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

9,500 Employees
Last Reported Date: 02/28/14
Founded in 1927

zimmer holdings inc (ZMH) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $904.0K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $525.7K
President of Europe, Middle East and Africa
Total Annual Compensation: $579.0K
President of Asia Pacific
Total Annual Compensation: $537.9K
Compensation as of Fiscal Year 2013.

zimmer holdings inc (ZMH) Key Developments

Zimmer Holdings, Inc. Announces Quarterly Dividend for Second Quarter of 2014, Payable on or About July 25, 2014

Zimmer Holdings, Inc. announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2014. The cash dividend of $0.22 per share will be paid on or about July 25, 2014, to stockholders of record as of the close of business on June 27, 2014.

Zimmer Holdings, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Revises Earnings Guidance for the Full Year Ending December 31, 2014

Zimmer Holdings, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were $1,161.5 million against $1,138.9 million a year ago. Operating profit was $298.4 million against $298.2 million a year ago. Earnings before income taxes were $285.9 million against $283.7 million a year ago. Net earnings were $221.1 million against $218.0 million a year ago. Net earnings of Zimmer Holdings, Inc. were $221.5 million or $1.29 diluted per share against $218.6 million or $1.28 diluted per share a year ago. Net cash provided by operating activities was $188.8 million against $180.5 million a year ago. Additions to instruments were $49.4 million against $57.5 million a year ago. Additions to other property, plant and equipment were $31.4 million against $17.9 million a year ago. Adjusted net earnings were $258.1 million or $1.50 diluted per share against $240.8 million or $1.41 diluted per share a year ago. Adjusted operating profit in the quarter amounted to $352 million at 30.3%. The significant improvement in adjusted operating margin in the quarter reflects the progress the company have made in restoring growth to certain geographic markets and higher-margin product categories within musculoskeletal portfolio. The company reaffirmed its full-year revenue and updated earnings guidance for 2014. Full-year revenues are still expected to increase approximately 3.0% to 5.0% on a constant currency basis from 2013. The Company continues to estimate that foreign currency translation will decrease revenues by approximately 0.5% for the full year, resulting in reported revenue growth between 2.5% and 4.5%. The company's earnings guidance has been updated to give effect to a change in the anticipated number of diluted weighted average shares outstanding for 2014. The number is expected to be higher as a result of the discontinuation of previously guided share repurchases ahead of the announced transaction with Biomet. The company now expects full-year 2014 diluted earnings per share to be in a range of $4.90 to $5.10 on a reported basis and $6.00 to $6.20 on an adjusted basis with the higher average shares. Prior guidance for full-year 2014 adjusted diluted earnings per share was $6.10 to $6.30. Consistent with the prior guidance, adjusted diluted earnings per share exclude estimated charges for inventory and manufacturing related expenses, quality and operational excellence initiatives, and special items of $250.0 million on a pre-tax basis, or approximately $1.10 per diluted share, on an after-tax basis. Additional costs connected to the pending transaction with Biomet which are not estimable at this time, shall also be excluded from the adjusted earnings measure.

Zimmer Holdings, Inc. to Report Q1, 2014 Results on Apr 24, 2014

Zimmer Holdings, Inc. announced that they will report Q1, 2014 results at 8:00 AM, US Eastern Standard Time on Apr 24, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZMH:US $103.27 USD +1.10

ZMH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Boston Scientific Corp $12.97 USD +0.12
Cerner Corp $55.35 USD +1.00
Hospira Inc $50.63 USD -0.15
Smith & Nephew PLC 1,059 GBp +11.00
St Jude Medical Inc $67.10 USD +0.05
View Industry Companies

Industry Analysis


Industry Average

Valuation ZMH Industry Range
Price/Earnings 23.0x
Price/Sales 3.7x
Price/Book 2.7x
Price/Cash Flow 22.4x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZIMMER HOLDINGS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at